E. V. van Puijenbroek
发表
S. van Buuren,
Peter G. M. van der Heijden,
E. V. van Puijenbroek,
2002,
Statistics in medicine.
A. Hoes,
A. Egberts,
H. Leufkens,
2002,
British journal of clinical pharmacology.
D. Madigan,
E. V. van Puijenbroek,
M. Hauben,
2005,
Expert opinion on drug safety.
M. Lindquist,
A. Bate,
A. Egberts,
2002,
Pharmacoepidemiology and drug safety.
R. Meyboom,
A. Egberts,
E. V. van Puijenbroek,
1999,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
J. Hazes,
W. Bramer,
2020,
Human reproduction update.
E. V. van Puijenbroek,
W. Bramer,
R. Dolhain,
2020,
Seminars in arthritis and rheumatism.
E. V. van Puijenbroek,
C. Gispen-de Wied,
J. Welink,
2009,
Journal of Neurology.
E. V. van Puijenbroek,
J. Kosterink,
P. L. Jager,
2020,
Drug Safety.
A. Egberts,
E. V. van Puijenbroek,
H. Leufkens,
2000,
European Journal of Clinical Pharmacology.
E. V. van Puijenbroek,
M. D. De Bruin,
N. Vermeer,
2015,
Drug Safety.
Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana
E. V. van Puijenbroek,
L. Härmark,
G. Sabblah,
2019,
Ghana medical journal.
E. V. van Puijenbroek,
F. van Hunsel,
S. van de Koppel,
2018,
Drug Safety.
B. Stricker,
E. V. van Puijenbroek,
G. Bleumink,
2002,
Clinical neuropharmacology.
E. V. van Puijenbroek,
E. Hak,
F. van Hunsel,
2017,
Pharmacoepidemiology and drug safety.
R. Meyboom,
E. V. van Puijenbroek,
H. Guchelaar,
2004,
Pharmacy World and Science.
E. V. van Puijenbroek,
J. Hazes,
R. Dolhain,
2020,
Drugs.
E. V. van Puijenbroek,
P. Mol,
J. Burgers,
2019,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
A. C. V. van Grootheest,
J. Passier,
2005,
Nederlands tijdschrift voor geneeskunde.
E. V. van Puijenbroek,
N. Roeleveld,
M. M. van Gelder,
2018,
American journal of epidemiology.
E. V. van Puijenbroek,
F. van Hunsel,
S. van de Koppel,
2015,
Drug Safety - Case Reports.
E. V. van Puijenbroek,
R. V. Schaik,
C. Ekhart,
2017,
Pharmacogenomics.
E. V. van Puijenbroek,
A. Bast,
M. Drent,
2020,
International journal of molecular sciences.
E. V. van Puijenbroek,
P. F. Spooren,
J. V. van Doormaal,
1996,
Journal of internal medicine.
E. V. van Puijenbroek,
K. Grootens,
R. V. van Marum,
2020,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
W. Knol,
I. Wilting,
2022,
European Geriatric Medicine.
E. V. van Puijenbroek,
A. C. V. van Grootheest,
2011,
The International journal of risk & safety in medicine.
E. V. van Puijenbroek,
W. Bramer,
R. Dolhain,
2020,
Sexual medicine reviews.
E. V. van Puijenbroek,
M. Nurmohamed,
B. V. D. van den Bemt,
2022,
Expert opinion on drug safety.
E. V. van Puijenbroek,
F. van Hunsel,
K. van Grootheest,
2014,
Birth defects research. Part A, Clinical and molecular teratology.
M. Lindquist,
A. Bate,
E. V. van Puijenbroek,
2017,
Drug Safety.
A. Verbeek,
E. V. van Puijenbroek,
N. Roeleveld,
2019,
Reproductive toxicology.
E. V. van Puijenbroek,
W. Knol,
I. Wilting,
2022,
European Geriatric Medicine.
K. Taxis,
E. V. van Puijenbroek,
F. van Hunsel,
2022,
PloS one.
E. V. van Puijenbroek,
K. Grootens,
R. V. van Marum,
2021,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
E. Hak,
S. de Vos,
2022,
Frontiers in Pharmacology.
E. V. van Puijenbroek,
A. Passier,
2005,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
J. Draaisma,
E. de Jong,
2022,
Pharmaceuticals.
N. Rodondi,
E. V. van Puijenbroek,
A. Spinewine,
2022,
Drug Safety.
E. V. van Puijenbroek,
N. Roeleveld,
M. M. van Gelder,
2017,
Journal of clinical epidemiology.
E. V. van Puijenbroek,
P. M. van de Ven,
Joep H G Scholl,
2015,
Journal of clinical epidemiology.
R. Meyboom,
E. V. van Puijenbroek,
W. Diemont,
1999,
Pharmacoepidemiology and Drug Safety.
E. V. van Puijenbroek,
A. Passier,
Astri Smits-van Herwaarden,
2004,
BMJ : British Medical Journal.
R. Meyboom,
A. Egberts,
E. V. van Puijenbroek,
2001,
Pharmacoepidemiology and drug safety.
E. V. van Puijenbroek,
A. C. V. van Grootheest,
J. Passier,
2010,
The Netherlands journal of medicine.
U. Bergman,
Judith K Jones,
E. V. van Puijenbroek,
2007,
Drug safety.
E. V. van Puijenbroek,
A. C. V. van Grootheest,
P. Hepburn,
2007,
Regulatory toxicology and pharmacology : RTP.
N. Moore,
U. Bergman,
E. V. van Puijenbroek,
2009,
Therapie.
M. Huiskes,
E. V. van Puijenbroek,
S. Borgsteede,
2010,
The Netherlands journal of medicine.
E. V. van Puijenbroek,
M. Heeringa,
1998,
Annals of Internal Medicine.
E. V. van Puijenbroek,
N. Srivastava,
J. Passier,
2006,
The Netherlands journal of medicine.
R. Meyboom,
E. V. van Puijenbroek,
M. Vinks,
1997,
The New Zealand medical journal.
R. Meyboom,
A. Egberts,
E. V. van Puijenbroek,
2002,
The Annals of pharmacotherapy.
E. V. van Puijenbroek,
J. Kosterink,
P. L. Jager,
2019,
Seminars in nuclear medicine.
Nel Roeleveld,
E. V. van Puijenbroek,
N. Roeleveld,
2018,
Drug Safety.
L. Morssink,
E. V. van Puijenbroek,
E. Hak,
2017,
Patient preference and adherence.
E. V. van Puijenbroek,
P. T. ten Klooster,
H. Vonkeman,
2021,
Expert opinion on drug safety.
E. V. van Puijenbroek,
P. T. ten Klooster,
H. Vonkeman,
2020,
Expert opinion on drug safety.
U. Bergman,
E. V. van Puijenbroek,
S. Olsson,
2021,
International journal of environmental research and public health.
U. Bergman,
E. V. van Puijenbroek,
S. Olsson,
2020,
Drug Safety.
B. Stricker,
R. Herings,
E. V. van Puijenbroek,
2001,
Arthritis and rheumatism.
E. V. van Puijenbroek,
A. Dittrich,
D. T. Loo,
2020,
Pediatric Drugs.
E. V. van Puijenbroek,
A. Bast,
M. Drent,
2019,
Current opinion in pulmonary medicine.
H. Tobi,
L. de Jong-van den Berg,
E. V. van Puijenbroek,
2004,
Pharmacoepidemiology and drug safety.
E. V. van Puijenbroek,
F. Hoentjen,
M. Russel,
2021,
Drug Safety.
E. V. van Puijenbroek,
N. Schreuder,
Quincy de Hoog,
2019,
Drug Safety - Case Reports.
P. Jansen,
E. V. van Puijenbroek,
A. de Boer,
2002,
International clinical psychopharmacology.
E. V. van Puijenbroek,
J. Kosterink,
P. L. Jager,
2020,
Drug Safety.
E. V. van Puijenbroek,
J. Kosterink,
P. L. Jager,
2021,
EJNMMI Radiopharmacy and Chemistry.
E. V. van Puijenbroek,
T. van Gelder,
E. V. van Bommel,
2020,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
M. V. van Agtmael,
M. Richir,
2017,
Naunyn-Schmiedeberg's Archives of Pharmacology.
K. Taxis,
E. V. van Puijenbroek,
F. van Hunsel,
2017,
Drug Safety.
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
H. J. Woerdenbag,
E. V. van Puijenbroek,
Zuzaan Zulzaga,
2021,
Journal of Pharmaceutical Policy and Practice.
E. Fliers,
R. Herings,
B. Wolffenbuttel,
2020,
Thyroid : official journal of the American Thyroid Association.
A. Egberts,
E. V. van Puijenbroek,
H. Leufkens,
2001,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
J. Kabel,
2005,
Nederlands tijdschrift voor geneeskunde.
E. V. van Puijenbroek,
F. van Hunsel,
A. Passier,
2010,
European Journal of Clinical Pharmacology.
E. V. van Puijenbroek,
P. Mol,
P. Denig,
2020,
Drug Safety.
K. Taxis,
O. Caster,
E. V. van Puijenbroek,
2018,
British journal of clinical pharmacology.
L. de Jong-van den Berg,
E. V. van Puijenbroek,
F. van Hunsel,
2011,
Pharmacoepidemiology and drug safety.
E. V. van Puijenbroek,
F. van Hunsel,
Joep H G Scholl,
2022,
Drug Safety.
E. V. van Puijenbroek,
L. Magro,
L. Härmark,
2018,
Drug Safety.
K. Taxis,
E. V. van Puijenbroek,
F. van Hunsel,
2016,
Drug Safety.
A. Hoes,
E. V. van Puijenbroek,
M. D. De Bruin,
2006,
Pharmacoepidemiology and drug safety.
E. V. van Puijenbroek,
P. Hepburn,
P. Zweers,
2012,
Regulatory toxicology and pharmacology : RTP.
N. Rodondi,
E. V. van Puijenbroek,
M. Spruit,
2021,
Drugs & Aging.
E. V. van Puijenbroek,
G. D'Haens,
M. Nurmohamed,
2021,
Expert opinion on drug safety.
M. Postma,
E. V. van Puijenbroek,
T. Fens,
2021,
Frontiers in Medical Technology.
K. Taxis,
E. V. van Puijenbroek,
E. Tommelein,
2021,
Pharmacy.
E. V. van Puijenbroek,
R. Bromley,
Bita Rezaallah,
2023,
Drug Safety.
E. V. van Puijenbroek,
L. van Dijk,
R. Verheij,
2022,
JMIR medical informatics.
E. V. van Puijenbroek,
E. Hak,
J. Bos,
2023,
Archives of Women's Mental Health.
E. V. van Puijenbroek,
Sieta T. de Vries,
C. Ekhart,
2018,
Drug Safety.
A. Egberts,
E. V. van Puijenbroek,
H. J. Krom,
1996,
International journal of clinical pharmacology and therapeutics.
E. V. van Puijenbroek,
M. Maliepaard,
D. Burger,
2020,
Clinical and translational science.
E. V. van Puijenbroek,
E. Hak,
F. van Hunsel,
2019,
Pharmacoepidemiology and drug safety.
E. V. van Puijenbroek,
W. Diemont,
L. de Graaf,
2003,
Pharmacy World and Science.
E. V. van Puijenbroek,
F. Hunsel,
A. Kant,
2021,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
L. Härmark,
K. van Grootheest,
2012,
European Journal of Clinical Pharmacology.
E. V. van Puijenbroek,
F. van Hunsel,
L. Rolfes,
2019,
Drug Safety.
E. V. van Puijenbroek,
M. Nurmohamed,
F. Hoentjen,
2023,
BioDrugs.
E. V. van Puijenbroek,
F. van Hunsel,
M. Ceulemans,
2022,
Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.
E. V. van Puijenbroek,
M. Nurmohamed,
F. Hoentjen,
2020,
Drug Safety.
E. V. van Puijenbroek,
J. Samijn,
L. Rolfes,
2013,
The Netherlands journal of medicine.
K. Taxis,
E. V. van Puijenbroek,
S. Borgsteede,
2020,
European Journal of Clinical Pharmacology.
M. Postma,
E. V. van Puijenbroek,
J. V. van Boven,
2021,
Expert opinion on pharmacotherapy.
E. V. van Puijenbroek,
A. Bast,
M. Drent,
2021,
Drug Safety.
E. V. van Puijenbroek,
K. Grootens,
F. Hoentjen,
2022,
Expert opinion on drug safety.
E. V. van Puijenbroek,
L. Härmark,
K. van Grootheest,
2012,
European Journal of Clinical Pharmacology.
R. Herings,
E. V. van Puijenbroek,
A. Porsius,
2002,
The Annals of pharmacotherapy.
E. V. van Puijenbroek,
M. Nurmohamed,
F. Hoentjen,
2021,
Annals of the Rheumatic Diseases.
E. V. van Puijenbroek,
M. Nurmohamed,
F. Hoentjen,
2020,
Expert opinion on drug safety.
E. V. van Puijenbroek,
G. Ekhart,
2014,
Tijdschrift voor psychiatrie.
E. V. van Puijenbroek,
Joep H G Scholl,
Rike van Eekeren,
2015,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
R. Dolhain,
J. Bergman,
2022,
British journal of clinical pharmacology.
E. V. van Puijenbroek,
F. van Hunsel,
L. Davidson,
2023,
British journal of clinical pharmacology.
G. N. Norén,
E. V. van Puijenbroek,
Eva-Lisa Meldau,
2022,
Drug Safety.
E. V. van Puijenbroek,
M. V. van Agtmael,
M. Richir,
2021,
European Journal of Clinical Pharmacology.
E. V. van Puijenbroek,
M. V. van Agtmael,
M. Richir,
2017,
Drug Safety.
E. V. van Puijenbroek,
A. C. V. van Grootheest,
L. de Jong‐van den Berg,
2002,
Pharmacoepidemiology and drug safety.
Bennett Kleinberg,
E. V. van Puijenbroek,
J. Murk,
2023,
medRxiv.
A. Egberts,
E. V. van Puijenbroek,
F. van Hunsel,
2023,
Frontiers in Drug Safety and Regulation.
E. V. van Puijenbroek,
J. Hazes,
R. Dolhain,
2022,
Lupus.
Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands.
E. V. van Puijenbroek,
N. Broos,
Kees van Grootheest,
2010,
Drug safety.
E. V. van Puijenbroek,
A. Bast,
M. Drent,
2019,
Current opinion in pulmonary medicine.
E. V. van Puijenbroek,
H. D. den Ruijter,
N. Onland-Moret,
2022,
JAMA network open.
R. Meyboom,
E. V. van Puijenbroek,
W. Diemont,
1999,
Pharmacoepidemiology and drug safety.
R. Meyboom,
E. V. van Puijenbroek,
J. Dekens-Konter,
1996,
Nederlands tijdschrift voor geneeskunde.
E. V. van Puijenbroek,
F. van Hunsel,
M. Wondergem,
2018,
Drug Safety - Case Reports.
E. V. van Puijenbroek,
B. V. D. van den Bemt,
H. Vonkeman,
2023,
Drug safety.
Bennett Kleinberg,
E. V. van Puijenbroek,
J. Murk,
2023,
Rheumatology and Therapy.
E. V. van Puijenbroek,
L. J. D. Berg,
F. van Hunsel,
2010,
Pharmacoepidemiology and drug safety.
E. V. van Puijenbroek,
J. Kosterink,
P. L. Jager,
2020,
Annals of Nuclear Medicine.
E. V. van Puijenbroek,
L. de Graaf,
Emil Verhoef,
2004,
BMJ : British Medical Journal.
Antoine Egberts,
Stephen Evans,
P. Waller,
2004,
Pharmacoepidemiology and Drug Safety.
L. de Jong-van den Berg,
E. V. van Puijenbroek,
Kees van Grootheest,
2004,
Pharmacy world & science : PWS.
E. V. van Puijenbroek,
M. Nurmohamed,
F. Hoentjen,
2020,
Expert opinion on drug safety.